Pain News and Research

Latest Pain News and Research

Any new pressure in upper body can signal heart attack

Not everyone who suffers a heart attack clutches their chest and falls to the floor. "I woke up and felt like a pill was stuck in my throat," says Betsy, a 68-year-old patient from Upper Providence. "I was taking antibiotics at the time and really didn't think much of it," she adds. "So I tried drinking water and when the "stuck" feeling didn't go away after 45 minutes, I thought something might be wrong."

15 Feb 2010

IMAI formally offered to purchase equity position in pharmaceutical operation

International Merchant Advisors, Inc. announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector.

15 Feb 2010

Adult stem cell transplant therapy may help prevent amputations from PAD

Grant Medical Center recently completed the nation's first published study of a new procedure that may give hope to millions of patients facing lower limb amputations from peripheral arterial disease (PAD). PAD is a painful circulatory problem in the legs that affects 10 million Americans. If left untreated, it can lead to serious complications such as stroke, amputation and death.

12 Feb 2010

President Bill Clinton undergoes stent insertion procedure: American Heart Association comments

Volunteers and staff of the American Heart Association extend their thoughts and well wishes to former President Bill Clinton upon the reports that he has undergone a procedure to insert stents to widen narrowed coronary arteries. President Clinton, who underwent quadruple coronary bypass surgery in 2004, partnered with the Association through his Foundation to jointly form the Alliance for a Healthier Generation to reduce the prevalence of childhood obesity in the United States.

12 Feb 2010

Humans are economical walkers, but not efficient runners

Humans, other great apes and bears are among the few animals that step first on the heel when walking, and then roll onto the ball of the foot and toes. Now, a University of Utah study shows the advantage: Compared with heel-first walking, it takes 53 percent more energy to walk on the balls of your feet, and 83 percent more energy to walk on your toes.

12 Feb 2010

New pain management options for patients undergoing knee or hip replacements

Patients undergoing knee or hip replacements recover more quickly when treated with targeted pain-blocking medications that may eliminate the need for general anesthesia during surgery and intravenous narcotics drugs after surgery.

12 Feb 2010

Mayo Clinic Health Letter features comprehensive coverage of the liver

The liver, the largest internal organ, is the body's ultimate multitasker. While the liver is not glamorous or sentimental -- there are no love songs about a broken liver -- it simultaneously plays a key role in the body's metabolic, digestive and regulatory systems.

12 Feb 2010

Better and standardized animal models needed for musculoskeletal regenerative medicine

Clinical testing and development of novel therapies based on advances in tissue engineering and regenerative medicine that will one day enable the repair and replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models.

12 Feb 2010

Third party reexamination of Phase III study of Ereska meets primary endpoint

Javelin Pharmaceuticals, Inc. today announced that a reexamination conducted by a third party of pain score measurements from its Phase III study of Ereska™ (intranasal ketamine) showed that top line results for its primary endpoint were statistically significant. Previously, Javelin had reported that the top line results for its primary endpoint were not statistically significant.

12 Feb 2010

Article features pelvic health problems, risk factors and treatment options for women

Pelvic health concerns in women are common -- yet how the issues impact sexuality and childbearing is not often discussed, according to Mayo Clinic Women's HealthSource.

12 Feb 2010

Wolters Kluwer Health releases optimized mobile website for Facts & Comparisons eAnswers

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has released an iPhone®/iPod touch® optimized mobile website for its industry leading drug information reference, Facts & Comparisons® eAnswers. The site, Facts & Comparisons Mobile, was developed in response to customer demand for convenient access to drug information via smart phones.

12 Feb 2010

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

12 Feb 2010

Parents often recognize signs of asthma in their children but delay home treatment: Report

Parents of young children with asthma often recognize signs that their child is about to have an asthma attack but delay home treatment until the attack occurs, researchers at Washington University School of Medicine in St. Louis report.

12 Feb 2010

Clinical research study conducted for patients with IC/PBS

A clinical research study is being conducted for patients with Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS), a chronic bladder disorder characterized by intense pelvic pain, urinary frequency-urgency, and pain during sexual intimacy (www.PainfulBladderStudy.org). It is estimated that as many as 1.3 million people in the U.S. have been diagnosed with this disease and many more remain undiagnosed.

12 Feb 2010

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, says Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women's HealthSource.

12 Feb 2010

Proving value a challenge for comparative effectiveness and pharmaceutical technologies

The Wall Street Journal reports that "an examination of one of the best-known examples of a comparative-effectiveness analysis shows how complicated such a seemingly straightforward idea can get" as officials look for savings in the health care system." One study, called Courage, "found that the most common heart surgery -- a $15,000 procedure that unclogs arteries using a small scaffold or stent -- usually yields no additional benefit when used with a cocktail of generic drugs in patients suffering from chronic chest pain."

12 Feb 2010

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it has begun distributing and selling Cobroxin through mass food and drug retail chains in the Northeast, Southeast, Middle Atlantic and Midwest regions.

12 Feb 2010

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage procedures for victims of the recent natural disasters in Haiti.

12 Feb 2010

iTech Medical signs manufacturing agreement with Thought Technology for MPR technology

iTech Medical, an information technology company, announced today that it has signed an exclusive, three-year manufacturing agreement with Thought Technology Ltd. of Montreal, Quebec for the Company’s proprietary Muscle Pattern Recognition (MPR) technology.

12 Feb 2010

Mayo Clinic provides treatment options for aging skin

Age or liver spots -- These flat, brown areas, also called solar lentigos, typically occur on the hands, back and face. Using a topical retinoid -- often in conjunction with bleaching cream and a mild topical steroid -- may gradually fade an age spot.

11 Feb 2010

Pain News and Research

Latest Pain News and Research

Any new pressure in upper body can signal heart attack

IMAI formally offered to purchase equity position in pharmaceutical operation

Adult stem cell transplant therapy may help prevent amputations from PAD

President Bill Clinton undergoes stent insertion procedure: American Heart Association comments

Humans are economical walkers, but not efficient runners

New pain management options for patients undergoing knee or hip replacements

Mayo Clinic Health Letter features comprehensive coverage of the liver

Better and standardized animal models needed for musculoskeletal regenerative medicine

Third party reexamination of Phase III study of Ereska meets primary endpoint

Article features pelvic health problems, risk factors and treatment options for women

Wolters Kluwer Health releases optimized mobile website for Facts & Comparisons eAnswers

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Parents often recognize signs of asthma in their children but delay home treatment: Report

Clinical research study conducted for patients with IC/PBS

Routine testing of hs-CRP in women with heart disease is controversial, says Mayo Clinic cardiologist

Proving value a challenge for comparative effectiveness and pharmaceutical technologies

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

iTech Medical signs manufacturing agreement with Thought Technology for MPR technology

Mayo Clinic provides treatment options for aging skin

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Pain News and Research

Latest Pain News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in